Prognostic Factors in Ewing's Sarcoma of the Foot

Roberto Casadei, Marina Magnani, Roberto Biagini, Mario Mercuri

Research output: Contribution to journalArticlepeer-review

Abstract

The outcome of treatment and prognostic factors were reviewed in 36 patients who had Ewing's sarcoma of the foot. The tumor was most common in the calcaneus (19 patients) and metatarsals (15 patients). Age, levels of lactate dehydrogenase, degree of anemia, tumor volume, type of surgery, and radiotherapy were not related to prognosis. Females with pain for less than 6 months, fever, high levels of erythrocyte sedimentation rate, and high levels of alkaline phosphatase showed a tendency for a poorer prognosis. The only observed prognostic factors are tumor site and treatment. Patients treated with four-drug neoadjuvant chemotherapy had the best survival. Four patients with metastatic disease at diagnosis died. Fourteen of 32 patients (44%) with localized Ewing's sarcoma were continuously disease-free at an average followup of 7 years.

Original languageEnglish
Pages (from-to)230-238
Number of pages9
JournalClinical Orthopaedics and Related Research
Issue number420
Publication statusPublished - Mar 2004

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Fingerprint Dive into the research topics of 'Prognostic Factors in Ewing's Sarcoma of the Foot'. Together they form a unique fingerprint.

Cite this